D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.34% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 6.92% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
MakeMyTrip
MMYT
$4.9B
| $317K | ﹤0.01% |
11,450
-131,333
| -92% | -$3.91M |
|
|
LSI
4502
DELISTED
Life Storage, Inc.
LSI
| $317K | ﹤0.01% |
2,071
-25,048
| -92% | -$3.35M |
|
4503
PUT
Oscar Health
OSCR
$8.69B
| $314K | ﹤0.01% |
+40,000
| New | +$502K |
|
4504
CALL
Canadian Solar
CSIQ
$944M
| $313K | ﹤0.01% |
10,000
| – | – |
|
4505
Matsons
MATX
$6.22B
| $312K | ﹤0.01% |
3,466
-4,447
| -56% | -$379K |
|
4506
John Wiley & Sons Class A
WLY
$2.59B
| $312K | ﹤0.01% |
5,456
-11,861
| -68% | -$641K |
|
4507
Main Street Capital
MAIN
$5.01B
| $311K | ﹤0.01% |
+6,922
| New | +$304K |
|
|
MRSN
4508
PUT
DELISTED
Mersana Therapeutics
MRSN
| $311K | ﹤0.01% |
2,000
| – | – |
|
4509
Intellia Therapeutics
NTLA
$1.54B
| $311K | ﹤0.01% |
2,634
-7,398
| -74% | -$927K |
|
4510
Steven Madden
SHOO
$3.2B
| $311K | ﹤0.01% |
6,691
-33,178
| -83% | -$1.53M |
|
4511
Digital Realty Trust
DLR
$72B
| $310K | ﹤0.01% |
1,755
-6,452
| -79% | -$1.03M |
|
|
MPX
4512
DELISTED
Marine Products Corp
MPX
| $308K | ﹤0.01% |
24,619
+13,253
| +117% | +$165K |
|
4513
Energy Vault
NRGV
$517M
| $308K | ﹤0.01% |
31,082
| – | – |
|
|
ANAT
4514
DELISTED
American National Group, Inc. Common Stock
ANAT
| $307K | ﹤0.01% |
1,626
-7,711
| -83% | -$1.46M |
|
4515
Carter Bankshares
CARE
$764M
| $306K | ﹤0.01% |
+19,907
| New | +$300K |
|
4516
West Pharmaceutical
WST
$23.5B
| $306K | ﹤0.01% |
+653
| New | +$281K |
|
4517
Neurogene
NGNE
$688M
| $305K | ﹤0.01% |
3,166
+1,858
| +142% | +$226K |
|
4518
Coursera
COUR
$1.59B
| $303K | ﹤0.01% |
+12,387
| New | +$377K |
|
4519
Albany International
AIN
$2.16B
| $302K | ﹤0.01% |
3,417
-2,856
| -46% | -$241K |
|
4520
i3 Verticals
IIIV
$405M
| $302K | ﹤0.01% |
13,233
-3,184
| -19% | -$71.4K |
|
4521
PUT
Snap-on
SNA
$20.9B
| $302K | ﹤0.01% |
1,400
-5,200
| -79% | -$1.11M |
|
|
SBNY
4522
DELISTED
Signature Bank
SBNY
| $301K | ﹤0.01% |
930
-17,912
| -95% | -$5.58M |
|
|
TRHC
4523
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $300K | ﹤0.01% |
20,000
| – | – |
|
|
ESGR
4524
DELISTED
Enstar Group
ESGR
| $299K | ﹤0.01% |
1,209
+7
| +0.6% | +$1.66K |
|
|
ZENV
4525
DELISTED
Zenvia
ZENV
| $299K | ﹤0.01% |
44,096
+20,035
| +83% | +$208K |
|
Similar funds
D.E. Shaw & Co's Q4 2021 Portfolio in Review
As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co's Q4 2021 filing shows 1,033 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
- D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- D.E. Shaw & Co opened 1,033 new positions and closed 616 in Q4 2021.
- D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.